Phase I Study of SPH1188-11 in NSCLC
NCT03231475
·
clinicaltrials.gov ↗
PHASE1
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class
Stopped
Board decision
Conditions
NSCLC Stage IIIB
NSCLC Stage IV
Interventions
DRUG:
SPH1188-11
Sponsor
Shanghai Pharmaceuticals Holding Co., Ltd